Show simple item record

dc.contributor.authorRendo, Matthew
dc.contributor.authorFranks, Teri J.
dc.contributor.authorGalvin, Jeffrey R.
dc.contributor.authorBerglund, Andrew
dc.contributor.authorVolk, Charles
dc.contributor.authorPeterson, Matthew
dc.date.accessioned2021-07-12T14:32:06Z
dc.date.available2021-07-12T14:32:06Z
dc.date.issued2021-07-07
dc.identifier.urihttp://hdl.handle.net/10713/16176
dc.description.abstractLight chain deposition disease is a rare condition that results in the deposition of light chains in organs and their subsequent dysfunction. It is often the consequence of unchecked light chain production by a plasma cell clone. Rarely does it manifest with solely pulmonary involvement, especially in the young otherwise healthy patient. This article highlights the presentation and diagnosis of pulmonary light chain deposition disease in an active duty solider, the discovery of a plasma cell clone responsible for his symptoms, and the therapy targeted at the plasma cell clone-inducing pulmonary disease. This therapy included a novel successful treatment with an autologous stem cell transplantation. To date, it is among the first such documented successful bone marrow transplantations in treatment of isolated pulmonary light chain deposition disease.en_US
dc.description.urihttps://doi.org/10.1016/j.chest.2021.02.041en_US
dc.language.isoenen_US
dc.publisherElsevier Ltd.en_US
dc.relation.ispartofChesten_US
dc.subjectlight chain deposition diseaseen_US
dc.subjectstem cellen_US
dc.subjecttherapyen_US
dc.subjecttransplantationen_US
dc.titleAutologous Stem Cell Transplantation in the Treatment of Pulmonary Light Chain Deposition Diseaseen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.chest.2021.02.041
dc.source.volume160
dc.source.issue1
dc.source.beginpagee13
dc.source.endpagee17


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record